88 coding-"https:"-"Prof"-"FEMTO-ST" "https:" "https:" "https:" "https:" "https:" "P" "Dr" uni jobs at Cardiff University
Sort by
Refine Your Search
-
hybrid working may be considered. For informal enquiries about the post, please contact Dr Emmanouil Perisoglou (Principal Investigator) at PerisoglouE@cardiff.ac.uk or Dr Juan Fernandez Goycoolea (Co
-
part of the UKRI-funded Future Leader Fellowship project investigating epigenetic regulation of lung fibrosis led by Dr Renata Jurkowska at the School of Biosciences, Cardiff University. You will work
-
UK and SMF. For informal enquiries candidates should contact Dr James Pearson (Pearsonj1@cardiff.ac.uk). This post is part time (14 hours per week), available immediately for 8 months. Flexible working
-
to appropriate standards. Expertise in mammalian cell culture and/or iPSC culture is essential. Dr Connor-Robson’s group centers on the use of cutting-edge induced pluripotent stem cell (iPSC) models to study the
-
to work in the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Emily Bates. This funding is awarded by UKRI Proof of Concept Grant and will evaluate precision
-
licensing, security, health, safety, environment and wellbeing, financial and other University policies, procedures and codes as appropriate. To provide a service to customers during arrivals / departures
-
codes. Maintain and update personal and professional knowledge through continuous professional development and keeping up to date with employment law and HR best practice. To perform other duties as
-
other University policies, procedures and codes as appropriate To take reasonable care for the health and safety of yourself and of other persons who may be affected by your acts or omissions at work in
-
and diversity, data protection, copyright and licensing, security, financial and other University policies, procedures and codes as appropriate. • Take reasonable care for the health and
-
the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL), in the research team of Dr Carly Bliss. This funding is awarded by Advancing Radiotherapy Cymru (ARC) and Cancer Research UK, and